This video features a comprehensive clinical-pathological correlation of Kaposi Sarcoma (KS), presented by dermatologist Dr. Josette McMichael and dermatopathologist Dr. Jared Gardner. Dr. McMichael details the four clinical variants (Classic, African Endemic, Iatrogenic, AIDS-related) and three stages (patch, plaque, tumor), emphasizing their diverse presentations, associated risk factors, and treatment strategies, including the role of immunosuppression modification and antiretroviral therapy. Dr. Gardner then provides a microscopic analysis, illustrating the histological features across the different stages, such as slit-like vascular spaces, spindle cell proliferation, eccrine coil infiltration, and the "Promontory sign." He highlights key differentiators from other vascular lesions like angiosarcoma and hemangiomas, particularly the absence of significant cellular atypia in most KS cases and the characteristic immunohistochemical staining pattern for HHV8 (LANA-1), which is crucial for definitive diagnosis.
Understanding Kaposi Sarcoma: Clinical Presentation and Pathological Features
0:00 Introduction to Kaposi Sarcoma (KS): Dr. Jared Gardner introduces a collaborative video on Kaposi Sarcoma, with Dr. Josette McMichael covering clinical aspects and Dr. Gardner detailing pathology.
KS is a vascular neoplasm caused by Human Herpes Virus 8 (HHV8), typically low-grade, multi-focal, and systemic.
Four Clinical Variants: Classic, African Endemic, Iatrogenic (transplantation-associated immunosuppression), and AIDS-related.
Three Stages: Patch (red/violaceous macules), Plaque (thickened lesions, various colors), and Tumor (larger nodules, often ulcerated), which can coexist.
Classic KS: Prevalent in older individuals (>50) of specific ethnic backgrounds (Mediterranean, Eastern European, Ashkenazi Jewish descent); primarily affects distal lower extremities; follows an indolent course, with potential systemic involvement and a risk of developing secondary malignancies (e.g., non-Hodgkin lymphoma).
African Endemic KS: Found in young children and middle-aged adults in Equatorial Africa, not linked to HIV; some aggressive forms, like the lymphadenopathic type in children, are often fatal.
Iatrogenic KS: Triggered by immunosuppression (e.g., post-organ transplant); may resolve if immunosuppressive therapy is reduced (e.g., by switching to sirolimus).
AIDS-related KS: The most aggressive variant, common in men who have sex with men (up to 40% incidence) and other HIV-positive individuals; frequently found on the trunk, mid-face (especially the nose), and internal organs (GI tract, lymph nodes, lungs); oral lesions warrant investigation for underlying GI involvement.
0:09:42 Differential Diagnosis: Clinically, KS can be confused with benign conditions like pseudo-Kaposi sarcoma (acroangiodermatitis) or even metastatic melanoma due to dark pigmentation; HHV8 testing is essential for accurate diagnosis.
0:10:10 Treatment Approaches: The main goals are symptom reduction, preventing disease progression, and improving cosmesis, as a definitive cure is uncommon.
Local Therapies: Surgery for symptomatic lesions, cryotherapy, laser therapy, photodynamic therapy, intralesional chemotherapy, and topical agents.
Key Management: Reducing immunosuppression for iatrogenic KS; observing stable classic KS; and using Highly Active Antiretroviral Therapy (HAART) as the primary treatment for AIDS-related KS, which can lead to lesion resolution in approximately half of patients over several months.
Microscopic features are consistent across clinical variants but vary significantly with the disease stage.
Patch Stage: Characterized by subtle changes including an increase in spindled endothelial cells that can mimic fibroblasts, slit-like vascular spaces, scattered red blood cells and hemosiderin, and a distinct infiltration of eccrine coils.
Plaque Stage: More cellular, displaying prominent cleft-like spaces filled with blood and hemosiderin, often accompanied by a plasma cell-rich inflammatory infiltrate.
Tumor Stage: Appears as a cellular nodule of spindle cells arranged in fascicles, with abundant blood-filled spaces that can be slit-like (in longitudinal sections) or sieve-like (small round holes in cross-sections). The cells typically have bland nuclei with occasional mitotic activity, but rarely show the marked pleomorphism seen in angiosarcoma. Hyalinized globules ("Dorf balls") may also be present.
0:18:24 Distinguishing KS from Other Vascular Tumors: It is critical to differentiate KS from aggressive angiosarcoma (KS cells are usually bland, angiosarcoma cells are highly atypical) and benign hemangiomas. Infiltration of eccrine coils and the unique HHV8 staining pattern are key diagnostic indicators.
0:43:45 Extracutaneous Involvement: KS can involve lymph nodes and other internal organs simultaneously; this is viewed as multifocal disease driven by the virus, not necessarily metastasis, differentiating its significance from that of other cancers like carcinoma or melanoma.
CD34: Generally strongly positive and more sensitive for KS than CD31.
CD31: Can be weak or negative, as the HHV8 virus may cause the breakdown of the CD31 protein.
ERG: Expected to be positive in most KS cases.
HHV8 (LANA-1): The definitive diagnostic marker, showing strong, diffuse, but sometimes focal, nuclear staining with a characteristic punctate or stippled pattern. A negative HHV8 stain should prompt re-evaluation of the diagnosis or consideration of repeating the test.